When GLP-1 medications come in a pre-filled auto-injector pen (like brand-name Ozempic or Mounjaro), dosing is nearly foolproof. The pen delivers a precise, pre-measured amount every time. But compounded medications come in multi-dose vials—and that introduces the possibility of dosing errors.
The FDA has issued multiple safety communications specifically about compounded GLP-1 dosing errors. These aren’t abstract concerns—they’ve resulted in hospitalizations. Understanding the risks and how to avoid them is critical for anyone using compounded semaglutide or tirzepatide.
FDA Safety Alert
The FDA has reported adverse events linked to dosing errors with compounded semaglutide, including cases where patients received 5–20 times the intended dose due to unit conversion mistakes. Symptoms of overdose include severe, prolonged nausea, vomiting, and dangerously low blood sugar.
The Most Common Dosing Errors
1. Milligram vs. Unit Confusion
This is the most dangerous and most common error. Compounded semaglutide vials are labeled by concentration—typically in milligrams per milliliter (mg/mL). But insulin syringes measure in “units.” These are not the same measurement system.
A patient prescribed 0.25mg of semaglutide from a 5mg/mL vial needs to draw 0.05mL (or 5 units on an insulin syringe). If they misread the prescription and draw 25 units (0.25mL), they’ll inject 1.25mg—five times the intended dose.
2. Wrong Syringe
Insulin syringes come in different sizes: U-100, U-40, and U-30. Using the wrong syringe type with the wrong concentration vial can result in significant dosing errors, even if the patient measures the correct number of units.
3. Concentration Confusion
Compounded semaglutide is available in multiple concentrations: 1mg/mL, 2.5mg/mL, 5mg/mL, and 10mg/mL. If a patient switches providers or receives a different concentration without adjusting the volume they draw, they could receive a dramatically different dose.
4. Titration Errors
Increasing the dose too quickly—or skipping titration steps entirely—is a common error, especially when patients self-adjust based on social media advice. The standard titration for semaglutide starts at 0.25mg weekly and increases every 4 weeks. Jumping from a starting dose to a therapeutic dose (2.4mg) can cause severe GI side effects.
How to Dose Correctly
The Golden Rule
Always confirm three things before injecting: (1) Your prescribed dose in milligrams, (2) the concentration of your vial in mg/mL, and (3) the volume to draw in your syringe. If any of these three don’t match what you expected, stop and call your provider.
Step-by-Step: Calculating Your Dose
The formula is straightforward:
Volume to Draw (mL) = Prescribed Dose (mg) ÷ Vial Concentration (mg/mL)
Example 1: Your prescription says 0.5mg of semaglutide. Your vial is 5mg/mL.
0.5mg ÷ 5mg/mL = 0.1mL = 10 units on an insulin syringe
Example 2: Your prescription says 1.0mg of semaglutide. Your vial is 2.5mg/mL.
1.0mg ÷ 2.5mg/mL = 0.4mL = 40 units on an insulin syringe
Example 3: Your prescription says 2.5mg of semaglutide. Your vial is 10mg/mL.
2.5mg ÷ 10mg/mL = 0.25mL = 25 units on an insulin syringe
What Good Providers Do Differently
The best telehealth GLP-1 providers have built safeguards into their process to minimize dosing errors:
- Clear dosing instructions: Written instructions that specify both the dose in milligrams AND the volume to draw, included with every shipment
- Pre-marked syringes: Some providers include syringes pre-marked at the correct fill line for each titration step
- Dosing cards: Visual reference cards showing exactly how far to fill the syringe for each dose
- Video demonstrations: Injection technique videos specific to the vial and syringe type provided
- Consistent concentrations: Using the same concentration throughout the titration schedule, adjusting only the volume drawn
- Accessible support: A pharmacist or nurse available to answer dosing questions
Signs of an Overdose
If you accidentally inject too much, symptoms may include:
- Severe, persistent nausea and vomiting (lasting 24+ hours)
- Severe abdominal pain
- Dangerously low blood sugar (shakiness, confusion, sweating, rapid heartbeat)
- Dehydration from prolonged vomiting or diarrhea
If You Suspect an Overdose
Contact your healthcare provider immediately or call Poison Control at 1-800-222-1222. If symptoms are severe (confusion, inability to keep fluids down, fainting), go to the emergency room. GLP-1 overdoses are treatable but can be dangerous if dehydration becomes severe.
The Bottom Line
Dosing errors with compounded GLP-1 medications are preventable. The math isn’t complicated, but it does require attention. Always verify your dose, your vial concentration, and the volume you’re drawing—every single time. Choose providers that include clear dosing instructions and offer accessible support for questions. And never adjust your dose on your own without talking to your prescribing provider first.